BeiGene Market Cap

BeiGene has a market cap or net worth of 229.95 billion as of April 2, 2025. Its market cap has increased by 65.60% in one year.

Market Cap

229.95B

Enterprise Value

217.91B

Revenue

29.60B

Ranking

n/a

PE Ratio

n/a

Stock Price

161.70

Market Cap Chart

Since February 3, 2016, BeiGene's market cap has increased from 6.70B to 229.95B, an increase of 3,333.80%. That is a compound annual growth rate of 47.09%.

Market Cap History

Date	Market Cap	% Change
Apr 1, 2025	226.78B	48.45%
Dec 31, 2024	152.77B	4.09%
Dec 29, 2023	146.76B	-17.60%
Dec 30, 2022	178.11B	-17.96%
Dec 31, 2021	217.12B	19.19%
Dec 31, 2020	182.15B	130.77%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hansoh Pharmaceutical Group Company	145.09B
JD Health International	107.67B
WuXi Biologics	107.56B
Innovent Biologics	81.66B
Alibaba Health Information Technology	77.20B
Akeso	77.19B
Sichuan Kelun-Biotech Biopharmaceutical	70.77B
Sino Biopharmaceutical	70.63B

Market Cap Rankings